CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-04 | JACOBS CINDY President & CMO | Option exercise | +110,000 | 143,214 | ||
| 2025-09-04 | JACOBS CINDY President & CMO | Sale | −27,629 | $2.77 | $77K | 115,585 |
| 2025-09-04 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −84,000 | 0 | ||
| 2025-09-04 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −26,000 | 104,000 | ||
| 2025-01-28 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +130,000 | 130,000 | ||
| 2024-08-16 | JACOBS CINDY President & CMO | Grant or award | +2,660 | $3.67 | $10K | 33,214 |
| 2024-04-19 | JACOBS CINDY President & CMO | Option exercise | +16,250 | 34,511 | ||
| 2024-04-19 | JACOBS CINDY President & CMO | Shares withheld for taxes | −3,957 | $4.51 | $18K | 30,554 |
| 2024-04-19 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −16,250 | 0 | ||
| 2024-01-22 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +84,000 | 84,000 | ||
| 2024-01-22 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2023-04-28 | JACOBS CINDY President & CMO | Option exercise | +2,500 | 18,870 | ||
| 2023-04-28 | JACOBS CINDY President & CMO | Shares withheld for taxes | −609 | $8.29 | $5K | 18,261 |
| 2023-04-28 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −2,500 | 0 | ||
| 2023-04-21 | JACOBS CINDY President & CMO | Shares withheld for taxes | −3,811 | $6.80 | $26K | 16,370 |
| 2023-04-21 | JACOBS CINDY President & CMO | Option exercise | +16,250 | 20,181 | ||
| 2023-04-21 | JACOBS CINDY President & CMO | Shares withheld for taxes | −4,819 | $6.80 | $33K | 15,362 |
| 2023-04-21 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | +16,250 | 16,250 | ||
| 2023-01-25 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +60,000 | 60,000 | ||
| 2023-01-25 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 |
Page 1 of 7 · 124 trades